DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon Cancer
Abigail L. Miller(Brigham and Women's Hospital), Karen Cichowski(Brigham and Women's Hospital)
Cited by 9
Related Papers
Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers
|Journal of Clinical Investigation|2016|43
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer
|Journal of Clinical Investigation|2023|20